Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proton Pump Inhibitor”

488 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 488 results

Large-scale testing (Phase 3)Study completedNCT01269788
What this trial is testing

Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial

Who this might be right for
Non-erosive Reflux Disease
Tehran University of Medical Sciences 144
Early research (Phase 1)Study completedNCT00600041
What this trial is testing

Placebo-Controlled Crossover Study for the Investigation of the Effect of Pantoprazole on Cardiac Contractility

Who this might be right for
Healthy
Herzzentrum Goettingen 20
Not applicableStudy completedNCT01139645
What this trial is testing

The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

Who this might be right for
Calcium Metabolism Disorders
American University of Beirut Medical Center 58
Post-approval studies (Phase 4)Study completedNCT03175731
What this trial is testing

PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)

Who this might be right for
Liver CirrhosisHypertension, Portal
Yanjing Gao 106
Early research (Phase 1)Study completedNCT04564040
What this trial is testing

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

Who this might be right for
Mantle Cell LymphomaCOVID-19
AstraZeneca 20
Early research (Phase 1)Study completedNCT05497557
What this trial is testing

Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acidic Beverage in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Amgen 16
Early research (Phase 1)Study completedNCT07141381
What this trial is testing

Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755

Who this might be right for
Healthy
Voronoi, Inc 25
Not applicableUnknownNCT03098537
What this trial is testing

Effects of Enteral Nutrition on Stress Ulcer Hemorrage. Multicenter Randomized Controlled Trial

Who this might be right for
Enteral NutritionGastro Intestinal BleedingStress Ulcer Prophylaxis+1 more
TC Erciyes University 500
Not applicableStudy completedNCT01647958
What this trial is testing

The EndoGastric Solutions TEMPO Trial

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
EndoGastric Solutions 65
Not applicableUnknownNCT05443789
What this trial is testing

Academic Detailing About Proton Pump Inhibitors

Who this might be right for
Prescription Pattern
Jón Þór Trærup Andersen 360
Not applicableStudy completedNCT03467893
What this trial is testing

Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population

Who this might be right for
Proton Pump Inhibitor
Fondation Hôpital Saint-Joseph 30
Early research (Phase 1)Study completedNCT02638116
What this trial is testing

A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults

Who this might be right for
Healthy
Janssen Research & Development, LLC 20
Early research (Phase 1)Study completedNCT05061563
What this trial is testing

Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes
Bayer 14
Not applicableStudy completedNCT05533619
What this trial is testing

Risk Factors and Machine Learning Model for Proton Pump Inhibitor Related Acute Kidney Injury

Who this might be right for
Proton Pump InhibitorAcute Kidney Injury
Qianfoshan Hospital 30,000
Testing effectiveness (Phase 2)Study completedNCT02637557
What this trial is testing

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Who this might be right for
Gastroesophageal Reflux Disease
Ironwood Pharmaceuticals, Inc. 282
Early research (Phase 1)UnknownNCT01905202
What this trial is testing

The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus

Who this might be right for
Barrett's Esophagus
Effexus Pharmaceutical 13
Not applicableWithdrawnNCT02039869
What this trial is testing

Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)

Who this might be right for
Gastroesophageal Reflux DiseaseNon Erosive Reflux DiseaseDyspepsia
Virginia Commonwealth University
Post-approval studies (Phase 4)Not Yet RecruitingNCT07312370
What this trial is testing

Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing

Who this might be right for
Early Gastric CancerGastric DysplasiaGastric Neoplasms+2 more
LanZhou University 120
Not applicableLooking for participantsNCT03312686
What this trial is testing

Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study

Who this might be right for
Eosinophilic Esophagitis
Indiana University 10
Large-scale testing (Phase 3)Study completedNCT00992589
What this trial is testing

Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)

Who this might be right for
Gastroesophageal Reflux
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 344
Next Page